Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 8/20 | 0.41 |
| ▸ | FDPS | P14324 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MLNR | O43193 | 1/20 | 0.40 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
| ▸ | FYN | P06241 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23418534 | 1.00 | LTA4H (0.41) | LTA4HFDPSCYP2D6MEN1LMNA | |
| Hydrochloric Acid SCHEMBL28272703 | 0.98 | LTA4H (0.41) | LTA4HFDPSCYP2D6MEN1LMNA | |
| SCHEMBL28254273 | 0.98 | CYP2D6 (0.43) | LTA4HFDPSCYP2D6MEN1LMNA | |
| SCHEMBL5021487 | 0.94 | — | — | |
| SCHEMBL27521887 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL27806461 | 0.92 | CHRNA3 (0.40) | LTA4H | |
| Acrylic Acid SCHEMBL28267416 | 0.87 | MEN1 (0.44) | LTA4HFDPSCYP2D6MEN1LMNA | |
| SCHEMBL28011980 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL28577065 | 0.81 | — | — | |
| SCHEMBL27554819 | 0.81 | KMT2A (0.39) | LTA4HFDPSCYP2D6MEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114426514-B | Large-scale synthesis method of natural alpha-glucosidase inhibitor Penosulfate A | 江汉大学 | 2023-10-24 | — | — | CN | claimed |
| CN-114426514-A | Large-scale synthesis method of natural alpha-glucosidase inhibitor Penasulfate A | 江汉大学 | 2022-05-03 | — | — | CN | claimed |
| CN-109232388-B | Synthetic method of natural alpha-glucosidase inhibitor Penasulfate A | 江汉大学 | 2021-11-16 | — | — | CN | claimed |
| CN-109232388-A | A kind of synthetic method of natural ɑ-glucosidase inhibitor Penasulfate A | 江汉大学 | 2019-01-18 | — | — | CN | claimed |
| CN-107827887-B | Triazole methyl esters link volution compound with antibacterial activity and its preparation method and application | 上海博栋化学科技有限公司 | 2019-01-08 | — | — | CN | claimed |
| US-11873291-B2 | Quinoline cGAS antagonist compounds | IMMUNESENSOR THERAPEUTICS, INC. (US) | 2024-01-16 | — | — | US | disclosed |
| CN-114426514-B | Large-scale synthesis method of natural alpha-glucosidase inhibitor Penosulfate A | 江汉大学 | 2023-10-24 | — | — | CN | disclosed |
| US-20220402841-A1 | Stilbene Derivative and Method for Preparing Same | Ozchela Inc. (KR) | 2022-12-22 | — | — | US | disclosed |
| CN-114426514-A | Large-scale synthesis method of natural alpha-glucosidase inhibitor Penasulfate A | 江汉大学 | 2022-05-03 | — | — | CN | disclosed |
| CN-110092753-B | Preparation method for synthesizing 3-azabicyclo [4.1.0] heptane-2-formic acid and hydrochloride thereof | 南京药石科技股份有限公司 | 2022-04-26 | — | — | CN | disclosed |
| CN-109232388-B | Synthetic method of natural alpha-glucosidase inhibitor Penasulfate A | 江汉大学 | 2021-11-16 | — | — | CN | disclosed |
| US-20190255009-A1 | STILBENE DERIVATIVE AND METHOD FOR PREPARING SAME | OZCHELA INC (KR) | 2019-08-22 | — | — | US | disclosed |
| CN-109232388-A | A kind of synthetic method of natural ɑ-glucosidase inhibitor Penasulfate A | 江汉大学 | 2019-01-18 | — | — | CN | disclosed |
| CN-108912111-A | compounds and pharmaceutical compositions | 铁木医药有限公司 | 2018-11-30 | — | — | CN | disclosed |
| CN-105408328-B | sGC stimulators | 铁木医药有限公司 | 2018-11-16 | — | — | CN | disclosed |
| CN-108699001-A | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | 因赛特公司 | 2018-10-23 | — | — | CN | disclosed |
| CN-108368090-A | Compounds as Immunomodulators | 百时美施贵宝公司 | 2018-08-03 | — | — | CN | disclosed |
| CN-106459032-A | Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection | 豪夫迈·罗氏有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-105517574-A | Combinations of hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2016-04-20 | — | — | CN | disclosed |
| CN-104302290-A | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2015-01-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190255009-A1 | STILBENE DERIVATIVE AND METHOD FOR PREPARING SAME | HPN, P4HB, FKBP1B | LTA4H 1104/4885FDPS 132/4885CYP2D6 494/4885 |
| US-20220402841-A1 | Stilbene Derivative and Method for Preparing Same | FKBP1B, FKBP8, FKBP2 | LTA4H 1430/4885FDPS 48/4885CYP2D6 2314/4885 |
| US-11873291-B2 | Quinoline cGAS antagonist compounds | CGAS, GLS2, GLS | LTA4H 2388/4885FDPS 2178/4885CYP2D6 1699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.